Archives

by in
Entry Author Date Location
Roche & Isis Join Forces on Antisense Drug for Huntington’s Disease 04/08/13 San Diego
Shedding Baggage, Alnylam Turns a Corner 02/21/13 Boston
San Diego Life Sciences Roundup: IPOs, ResMed, Ventrix, CovX, & More 02/21/13 San Diego
Poll: Which of These 10 New Drugs Is Priced Too High? 02/11/13 National
RNA Therapeutics Are Coming of Age 02/08/13 San Diego
East Coast Life Sciences Roundup: Sarepta, Vertex, Celsion, More 02/01/13 Boston
San Diego Life Sciences Roundup: Isis, Afraxis, Organovo, & More 01/31/13 San Diego
FDA OKs First-in-Class Drug From Isis for Rare Cholesterol Disorder 01/29/13 San Diego
San Diego Life Sciences Roundup: Acadia, Zogenix, Isis, & More 12/14/12 San Diego
Isis Pharmaceuticals Adds More Deals to Partnership Portfolio 12/12/12 San Diego
Who Are Biotech’s New Go-To Investment Bankers? 11/12/12 National
San Diego Life Sciences Roundup: Regulus IPO, Fate Funding, & More 08/23/12 San Diego
Regulus Therapeutics Files for IPO as ‘Emerging Growth’ Company 08/20/12 San Diego
Two Years After Rising from Ashes, Aegerion Preps for Drug Debut 08/09/12 Boston
Biogen Idec, Isis Forge 2nd Alliance This Year for Rare Disease 06/29/12 Boston
BioPharma Needs A Safe, Reliable Way To Repair Broken Genes 04/11/12 Seattle
San Diego Life Sciences Roundup: Isis, Elevation, Proacta, and More 01/06/12 San Diego
Alnylam, Aveo, Biogen, & More Boston Life Sciences Newsmakers 01/06/12 Boston
Isis, Biogen Strike Potential $299M Deal For Rare Spine Disorder Treatment 01/04/12 San Diego
Alnylam Gets First Hint of Effectiveness for RNAi Cholesterol-Lowering Drug 01/04/12 Boston
The Top 10 Traffic-Getting Stories at Xconomy San Diego 12/28/11 San Diego
Buyouts, Quantified Health, & More San Diego Life Sciences News 12/01/11 San Diego
Pfizer Acquires Excaliard, an Isis Spinout With Drug to Fight Excessive Scarring 11/22/11 San Diego
Orexigen’s Diet Drug Springs Back to Life, Independa Gets $1.6M, NuVasive Faces Big Judgments in Patent Dispute, & More San Diego Life Sciences News 09/22/11 San Diego
AVI Biopharma CEO Chris Garabedian Seeks to Avoid Quick Flip, Build Enduring Drug Company 06/02/11 Seattle
AVI Biopharma Adds Chief Scientist 03/28/11 Seattle
Astute Medical Nabs $13M, Roth Capital Hosts Conference, Kaldor Joins Versant, & More San Diego Life Sciences News 03/10/11 San Diego
Alder Steers Next Antibodies To Unusual Places: Treating Migraines and High Cholesterol 03/02/11 Seattle
Illumina Rides Business Surge, IntegenX Acquires GenValult, Orexigen Cuts Payroll, & More San Diego Life Science News 02/10/11 San Diego
Regulus, the MicroRNA Child of Alnylam and Isis, Offers Litmus Test for Biotech Hope in 2011 02/07/11 San Diego
Page 1 of 4 next page »